Jitske Bak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jitske Bak has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Anastassis Perrakis
The Netherlands Cancer Institute
2 shared publications Alessia Anania
Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, The Netherlands
1 shared publicationAnouk H. A. Verboven
Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, The Netherlands
1 shared publicationAstrid Oudakker
Department of Human Genetics, Radboudumc, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, The Netherlands
1 shared publication- Athanassios Adamopoulos
Netherlands Cancer Institute
1 shared publication - Britt Mossink
Department of Human Genetics, Radboud University Medical Center
1 shared publication
Latest Publications
- Open Access
- 29 March 2025
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 7 (2) , lqaf045
Detecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data
It has become clear in recent years that ribosomes regularly stall during translation. Such translation impairment has many causes, including exposure to ribotoxic stress agents, the presence of specific RNA structures or sequences, or a shortage of amino acids or translation factors. If they are not resolved, stalled ribosomes can lead to ribosome collisions that are continuously surveilled by various sensor proteins. This in turn initiates a cascade of signalling events that can change the physiology and behaviour of cells. However, measuring changes in collision abundance has proved challenging, and as a result, the importance of collision-mediated biological responses is still unclear. Here, we show that computational analyses of standard ribosome profiling (Ribo-seq) data enable the prediction of changes in ribosome collisions between conditions. This is achieved by using the known 3D structure of collided ribosomes to define the ribosomal RNA (rRNA) positions that are differentially digested by RNases during the Ribo-seq protocol. Comparison of the relative rRNA reads at these positions allows the relative quantification of collisions between samples, an approach we call differential ribosome collisions by Analysis of rRNA Fragments (dricARF). When applied to public datasets across multiple organisms, our approach detects changes in collision events with unprecedented accuracy and sensitivity. In addition to providing supplementary evidence for ribosome collisions, our tool has the potential to uncover novel biological processes that are mediated by them. dricARF is available as part of the ARF R package and can be accessed through https://github.com/fallerlab/ARF.
- 29 March 2025
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 7 (2) , lqaf045
Open AccessDetecting ribosome collisions with differential rRNA fragment analysis in ribosome profiling data
It has become clear in recent years that ribosomes regularly stall during translation. Such translation impairment has many causes, including exposure to ribotoxic stress agents, the presence of specific RNA structures or sequences, or a shortage of amino acids or translation factors. If they are not resolved, stalled ribosomes can lead to ribosome collisions that are continuously surveilled by various sensor proteins. This in turn initiates a cascade of signalling events that can change the physiology and behaviour of cells. However, measuring changes in collision abundance has proved challenging, and as a result, the importance of collision-mediated biological responses is still unclear. Here, we show that computational analyses of standard ribosome profiling (Ribo-seq) data enable the prediction of changes in ribosome collisions between conditions. This is achieved by using the known 3D structure of collided ribosomes to define the ribosomal RNA (rRNA) positions that are differentially digested by RNases during the Ribo-seq protocol. Comparison of the relative rRNA reads at these positions allows the relative quantification of collisions between samples, an approach we call differential ribosome collisions by Analysis of rRNA Fragments (dricARF). When applied to public datasets across multiple organisms, our approach detects changes in collision events with unprecedented accuracy and sensitivity. In addition to providing supplementary evidence for ribosome collisions, our tool has the potential to uncover novel biological processes that are mediated by them. dricARF is available as part of the ARF R package and can be accessed through https://github.com/fallerlab/ARF.
- Open Access
Disentangling the CHAOS of intrinsic disorder in human proteins
Most proteins consist of both folded domains and Intrinsically Disordered Regions (IDRs). However, the widespread occurrence of intrinsic disorder in human proteins, along with its characteristics, is often overlooked by the broader communities of structural and molecular biologists. Building on the MobiDB database of intrinsic disorder in proteins, here we develop a comprehensive dataset ( C omprehensive analysis of Human proteins A nd their dis O rdered Segments - CHAOS). We implement internally consistent definitions of disordered regions, and annotate general characteristics such as cellular location, essentiality, post-translational modifications, and predicted pathogenicity. Further, we cross-reference to structure predictions from AlphaFold. We find that most human proteins contain at least one disordered region, predominantly located at the protein termini. IDRs are less hydrophobic, enriched in post-translational modifications, and mutations in IDRs are predicted to be less pathogenic than in non-IDRs. Additionally, we discovered that proteins residing in different cellular locations possess distinct disorder profiles. Finally, the predicted AlphaFold models of proteins in CHAOS suggest that disordered regions and proteins are often predicted to adopt secondary structure. Hereby we enhance the visibility and understanding of intrinsic disorder in human proteins. Key messages: Four out of five human proteins contain one or more intrinsically disordered regions (IDRs). Half of the IDRs are located at protein termini, but three quarters of all human proteins contain a terminal IDR. The amount and location of disordered regions differs throughout cellular compartments. One in five missense mutations in IDRs are likely pathogenic. AlphaFold predicts secondary structure elements within intrinsically disordered regions and fully disordered proteins.
Open AccessDisentangling the CHAOS of intrinsic disorder in human proteins
Most proteins consist of both folded domains and Intrinsically Disordered Regions (IDRs). However, the widespread occurrence of intrinsic disorder in human proteins, along with its characteristics, is often overlooked by the broader communities of structural and molecular biologists. Building on the MobiDB database of intrinsic disorder in proteins, here we develop a comprehensive dataset ( C omprehensive analysis of Human proteins A nd their dis O rdered Segments - CHAOS). We implement internally consistent definitions of disordered regions, and annotate general characteristics such as cellular location, essentiality, post-translational modifications, and predicted pathogenicity. Further, we cross-reference to structure predictions from AlphaFold. We find that most human proteins contain at least one disordered region, predominantly located at the protein termini. IDRs are less hydrophobic, enriched in post-translational modifications, and mutations in IDRs are predicted to be less pathogenic than in non-IDRs. Additionally, we discovered that proteins residing in different cellular locations possess distinct disorder profiles. Finally, the predicted AlphaFold models of proteins in CHAOS suggest that disordered regions and proteins are often predicted to adopt secondary structure. Hereby we enhance the visibility and understanding of intrinsic disorder in human proteins. Key messages: Four out of five human proteins contain one or more intrinsically disordered regions (IDRs). Half of the IDRs are located at protein termini, but three quarters of all human proteins contain a terminal IDR. The amount and location of disordered regions differs throughout cellular compartments. One in five missense mutations in IDRs are likely pathogenic. AlphaFold predicts secondary structure elements within intrinsically disordered regions and fully disordered proteins.
- 20 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6595) , 815-+
Posttranslational modification of microtubules by the MATCAP detyrosinase
The detyrosination-tyrosination cycle involves the removal and religation of the C-terminal tyrosine of α-tubulin and is implicated in cognitive, cardiac, and mitotic defects. The vasohibin–small vasohibin-binding protein (SVBP) complex underlies much, but not all, detyrosination. We used haploid genetic screens to identify an unannotated protein, microtubule associated tyrosine carboxypeptidase (MATCAP), as a remaining detyrosinating enzyme. X-ray crystallography and cryo–electron microscopy structures established MATCAP’s cleaving mechanism, substrate specificity, and microtubule recognition. Paradoxically, whereas abrogation of tyrosine religation is lethal in mice, codeletion of MATCAP and SVBP is not. Although viable, defective detyrosination caused microcephaly, associated with proliferative defects during neurogenesis, and abnormal behavior. Thus, MATCAP is a missing component of the detyrosination-tyrosination cycle, revealing the importance of this modification in brain formation.
- 20 May 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 376 (6595) , 815-+
Posttranslational modification of microtubules by the MATCAP detyrosinase
The detyrosination-tyrosination cycle involves the removal and religation of the C-terminal tyrosine of α-tubulin and is implicated in cognitive, cardiac, and mitotic defects. The vasohibin–small vasohibin-binding protein (SVBP) complex underlies much, but not all, detyrosination. We used haploid genetic screens to identify an unannotated protein, microtubule associated tyrosine carboxypeptidase (MATCAP), as a remaining detyrosinating enzyme. X-ray crystallography and cryo–electron microscopy structures established MATCAP’s cleaving mechanism, substrate specificity, and microtubule recognition. Paradoxically, whereas abrogation of tyrosine religation is lethal in mice, codeletion of MATCAP and SVBP is not. Although viable, defective detyrosination caused microcephaly, associated with proliferative defects during neurogenesis, and abnormal behavior. Thus, MATCAP is a missing component of the detyrosination-tyrosination cycle, revealing the importance of this modification in brain formation.
- Top Cited PapersOpen Access
- 10 May 2021
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (1) , 1-18
Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks
Activity in the healthy brain relies on a concerted interplay of excitation (E) and inhibition (I) via balanced synaptic communication between glutamatergic and GABAergic neurons. A growing number of studies imply that disruption of this E/I balance is a commonality in many brain disorders; however, obtaining mechanistic insight into these disruptions, with translational value for the patient, has typically been hampered by methodological limitations.Cadherin-13(CDH13) has been associated with autism and attention-deficit/hyperactivity disorder. CDH13 localizes at inhibitory presynapses, specifically of parvalbumin (PV) and somatostatin (SST) expressing GABAergic neurons. However, the mechanism by which CDH13 regulates the function of inhibitory synapses in human neurons remains unknown. Starting from human-induced pluripotent stem cells, we established a robust method to generate a homogenous population of SST and MEF2C (PV-precursor marker protein) expressing GABAergic neurons (iGABA) in vitro, and co-cultured these with glutamatergic neurons at defined E/I ratios on micro-electrode arrays. We identified functional network parameters that are most reliably affected by GABAergic modulation as such, and through alterations of E/I balance by reduced expression of CDH13 in iGABAs. We found that CDH13 deficiency in iGABAs decreased E/I balance by means of increased inhibition. Moreover, CDH13 interacts with Integrin-β1 and Integrin-β3, which play opposite roles in the regulation of inhibitory synaptic strength via this interaction. Taken together, this model allows for standardized investigation of the E/I balance in a human neuronal background and can be deployed to dissect the cell-type-specific contribution of disease genes to the E/I balance.
- 10 May 2021
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (1) , 1-18
Top Cited PapersOpen AccessCadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks
Activity in the healthy brain relies on a concerted interplay of excitation (E) and inhibition (I) via balanced synaptic communication between glutamatergic and GABAergic neurons. A growing number of studies imply that disruption of this E/I balance is a commonality in many brain disorders; however, obtaining mechanistic insight into these disruptions, with translational value for the patient, has typically been hampered by methodological limitations.Cadherin-13(CDH13) has been associated with autism and attention-deficit/hyperactivity disorder. CDH13 localizes at inhibitory presynapses, specifically of parvalbumin (PV) and somatostatin (SST) expressing GABAergic neurons. However, the mechanism by which CDH13 regulates the function of inhibitory synapses in human neurons remains unknown. Starting from human-induced pluripotent stem cells, we established a robust method to generate a homogenous population of SST and MEF2C (PV-precursor marker protein) expressing GABAergic neurons (iGABA) in vitro, and co-cultured these with glutamatergic neurons at defined E/I ratios on micro-electrode arrays. We identified functional network parameters that are most reliably affected by GABAergic modulation as such, and through alterations of E/I balance by reduced expression of CDH13 in iGABAs. We found that CDH13 deficiency in iGABAs decreased E/I balance by means of increased inhibition. Moreover, CDH13 interacts with Integrin-β1 and Integrin-β3, which play opposite roles in the regulation of inhibitory synaptic strength via this interaction. Taken together, this model allows for standardized investigation of the E/I balance in a human neuronal background and can be deployed to dissect the cell-type-specific contribution of disease genes to the E/I balance.